These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Odvina CV, Mason RP, Pak CY. Am J Ther; 2006 Nov; 13(2):101-8. PubMed ID: 16645424 [Abstract] [Full Text] [Related]
6. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion. Frassetto LA, Nash E, Morris RC, Sebastian A. Kidney Int; 2000 Aug; 58(2):748-52. PubMed ID: 10916098 [Abstract] [Full Text] [Related]
8. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. Nicar MJ, Peterson R, Pak CY. J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979 [Abstract] [Full Text] [Related]
9. Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Odvina CV, Preminger GM, Lindberg JS, Moe OW, Pak CY. Kidney Int; 2003 Jan; 63(1):240-7. PubMed ID: 12472789 [Abstract] [Full Text] [Related]
10. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. Koenig K, Padalino P, Alexandrides G, Pak CY. J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724 [Abstract] [Full Text] [Related]
11. Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects. Vongpatanasin W, Peri-Okonny P, Velasco A, Arbique D, Wang Z, Ravikumar P, Adams-Huet B, Moe OW, Pak CYC. Am J Cardiol; 2016 Sep 15; 118(6):849-853. PubMed ID: 27448942 [Abstract] [Full Text] [Related]
14. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. Pak CY, Koenig K, Khan R, Haynes S, Padalino P. J Bone Miner Res; 1992 Mar 15; 7(3):281-5. PubMed ID: 1585829 [Abstract] [Full Text] [Related]
15. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. J Urol; 2007 Jun 15; 177(6):2179-84. PubMed ID: 17509313 [Abstract] [Full Text] [Related]
16. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia. Papademetriou V, Burris J, Kukich S, Freis ED. Arch Intern Med; 1985 Nov 15; 145(11):1986-90. PubMed ID: 3904654 [Abstract] [Full Text] [Related]
17. Effect of potassium-magnesium citrate on upper gastrointestinal mucosa. Gonzalez GB, Pak CY, Adams-Huet B, Taylor R, Bilhartz LE. Aliment Pharmacol Ther; 1998 Jan 15; 12(1):105-10. PubMed ID: 9692708 [Abstract] [Full Text] [Related]
18. Contrasting effects of various potassium salts on renal citrate excretion. Sakhaee K, Alpern R, Jacobson HR, Pak CY. J Clin Endocrinol Metab; 1991 Feb 15; 72(2):396-400. PubMed ID: 1899422 [Abstract] [Full Text] [Related]
19. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P. J Med Assoc Thai; 2004 Mar 15; 87(3):255-63. PubMed ID: 15117041 [Abstract] [Full Text] [Related]
20. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene. Kohvakka A. Int J Clin Pharmacol Ther Toxicol; 1988 May 15; 26(5):273-7. PubMed ID: 3045028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]